Preferred Label : vandetanib;

MeSH note : a VEGF receptor tyrosine kinase inhibitor; structure in first source;

CISMeF synonym : ZD 6474; zactima;

MeSH synonym : N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine;

MeSH hyponym : ZD6474; ZD-6474; ZD-64;

Is substance : O;

UNII : YO460OQ37K;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2912132/fr/caprelsa
2019
false
true
false
false
France
administration, oral
treatment outcome
vandetanib
insurance, health, reimbursement
protein kinase inhibitors
adult
adolescent
child
thyroid cancer, medullary
neoplasm metastasis
caprelsa
piperidines
quinazolines
evaluation of the transparency committee
vandetanib
piperidines
quinazolines
carcinoma, neuroendocrine
thyroid neoplasms

---
https://ansm.sante.fr/tableau-marr/vandetanib
2018
false
false
false
France
French
risk management
vandetanib
vandetanib
Cardiotoxicity
adult
child
posterior leukoencephalopathy syndrome
death, sudden
long qt syndrome
torsades de pointes
continuity of patient care
drug monitoring
drug interactions
medication errors
vandetanib
handbooks
popular works
piperidines
quinazolines
piperidines
quinazolines

---
Summary Basis of Decision (SBD) for Caprelsa
Vandetanib, 100 mg, 300 mg, Tablet, Oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00025
2012
false
Canada
French
English
drug information
Tyrosine Kinase Inhibitors
thyroid cancer, medullary
piperidines
piperidines
quinazolines
quinazolines
administration, oral
vandetanib
vandetanib
protein kinase inhibitors
protein kinase inhibitors
vandetanib
receptor Protein-Tyrosine kinases
adult
thyroid neoplasms
neoplasm metastasis
treatment outcome
risk assessment
antineoplastic agents
antineoplastic agents
drug evaluation, preclinical
clinical trials, phase iii as topic
randomized controlled trials as topic
disease-free survival
Medullary thyroid carcinoma

---
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/14117a-fra.php
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/14671a-fra.php
2012
false
Canada
English
French
pharmacovigilance note
patient education handout
Cardiotoxicity
carcinoma, medullary
vandetanib
arrhythmias, cardiac
risk
vandetanib
death, sudden, cardiac
long qt syndrome
torsades de pointes
thyroid neoplasms
antineoplastic agents
adult
neoplasm metastasis
piperidines
quinazolines

---
Nous contacter.
29/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.